Skip to main content
Guide

What to Look for in a Probiotic — Evidence-Based 2026

Strain specificity beats CFU count every time. Learn the 3 label clues that separate clinically backed probiotics from marketing noise in 2026.

·10 min read
By Formulate Team · Independent supplement research
Key Takeaways
8 min read
  • Strain specificity is the #1 factor — L. rhamnosus GG has 1,000+ studies; a different L. rhamnosus strain may have zero
  • Most clinical trials showing real benefits use 1-20 billion CFU — not the 100+ billion marketed by many brands
  • If a probiotic doesn't list specific strain designations (the letters after the species), you can't evaluate its evidence
  • Match the strain to your goal: S. boulardii for antibiotics, LP299V for IBS bloating, LGG for general gut health

The most important thing to look for in a probiotic is the specific strain listed on the label — not the CFU count, not the number of strains, and not broad health claims. Strain identity is what links a product to actual clinical evidence, yet most probiotic labels omit it entirely, listing only genus and species. A high CFU number without a clinically studied strain behind it tells you almost nothing useful.

The probiotic industry has a unique issue that most supplement categories don’t — the thing that actually determines whether a probiotic works (the specific strain) is the thing most products don’t even list on the label.

The One Thing Most People Get Wrong

When people shop for probiotics, they look at CFU count (how many organisms), maybe the number of strains, and the price. These are the three least important factors. The single most important factor is one that most consumers don’t even know to look for: strain specificity.

⚠️The #1 red flag
If a probiotic product doesn’t list specific strain designations (the letters/numbers after the species name), you literally cannot evaluate whether it has any evidence behind it. L. rhamnosus GG has over 1,000 published studies. A different L. rhamnosus strain may have zero. Same species, completely different evidence.

A probiotic organism is identified by three parts: genus, species, and strain. For example: Lactobacillus rhamnosus GG. That last part — GG — is the strain designation. And it makes all the difference.

Lactobacillus rhamnosus GG has been the subject of over 1,000 published studies. It has strong evidence for preventing antibiotic-associated diarrhea, reducing IBS symptoms, and supporting immune function in children. A different strain of Lactobacillus rhamnosus — say, one with no strain designation or a different code — may have zero clinical evidence. Same genus. Same species. Completely different evidence base.

CFU Count: Why Bigger Isn’t Better

The marketing arms race around CFU (Colony Forming Units) has gotten absurd. Products now advertise 100 billion, 200 billion CFU. The implication is that more = better. The research says otherwise.

📊What the research actually uses
Most clinical trials showing real benefits use 1–20 billion CFU of specific strains. The studies demonstrating L. rhamnosus GG’s benefits used 10 billion CFU. S. boulardii for antibiotic-associated diarrhea? 5–10 billion CFU. B. longum 35624 for IBS? Just 1 billion. Strong evidence

What actually matters about CFU:

  • CFU at expiration, not at manufacture. Probiotics die over time. Heat, moisture, and oxygen kill them. A product boasting “100 billion at time of manufacture” might deliver 10 billion by the time you open it. The only number that matters is what’s guaranteed through the expiration date. If the label doesn’t specify, assume the worst.
  • CFU per strain, not per blend. “50 billion CFU from 30 strains” sounds impressive. But that’s an average of 1.6 billion per strain — potentially below clinical thresholds for any of them. What you want is a product with clinically studied doses of a few well-chosen strains, not a shotgun blast of 30.
  • Survival matters more than quantity. 100 billion organisms that die in stomach acid before reaching your intestines are worth less than 5 billion that actually survive the trip. Which brings us to delivery.

The Strains Worth Knowing About

If a product contains one of these strains at the studied dose, it has real evidence behind it — not just marketing:

  • Lactobacillus rhamnosus GG (LGG): The most studied probiotic strain in the world. Strong evidence for antibiotic-associated diarrhea prevention, IBS symptom reduction, and pediatric gastroenteritis. Studied at 10–20 billion CFU. Strong evidence
  • Saccharomyces boulardii (CNCM I-745): Not a bacterium — it’s a yeast. And that’s its superpower: it’s naturally antibiotic-resistant, so you can take it during an antibiotic course without it being killed. Strong evidence for C. difficile prevention and traveler’s diarrhea. Studied at 5–10 billion CFU. Strong evidence
  • Bifidobacterium lactis BB-12: One of the best-documented bifidobacteria. Evidence for improved regularity, immune function in infants, and gut barrier integrity. Studied at 1–10 billion CFU. Strong evidence
  • Lactobacillus plantarum 299v (LP299V): Specifically studied for IBS, particularly bloating and abdominal pain. Multiple RCTs showing benefit. Studied at 10–20 billion CFU. Strong evidence
  • Bifidobacterium longum 35624: Also known as Alflorex®. Evidence from multiple trials for IBS symptom improvement (bloating, pain, bowel habit). Studied at 1 billion CFU — proving that low-dose, single-strain products can be highly effective. Strong evidence
💡Match strain to goal
“I want better gut health” isn’t specific enough. “I get IBS bloating” points you toward LP299V or B. longum 35624. “I’m going on antibiotics” points you toward S. boulardii. This is strain-specific medicine, not one-size-fits-all.

Delivery: Getting Them There Alive

Your stomach has a pH of 1.5–3.5. That’s acidic enough to dissolve metal. Most probiotic bacteria die in it. How a product handles this determines whether you’re swallowing live organisms or expensive dead ones.

  • Enteric-coated or delayed-release capsules: These resist stomach acid and dissolve in the less acidic environment of the small intestine. This is the most reliable delivery method for acid-sensitive strains.
  • Spore-based probiotics: Bacillus strains naturally form protective endospores — essentially armor plating that survives stomach acid, heat, and even boiling water. They don’t need refrigeration and have excellent shelf stability. The tradeoff: they’re a different category of organism than Lactobacillus and Bifidobacterium, with a different (and smaller) evidence base.
  • Taking with food: Eating buffers stomach acid and can improve survival. Some studies suggest taking probiotics with a meal (especially one containing some fat) is optimal for conventional capsules.
  • Refrigerated products: Many Lactobacillus and Bifidobacterium strains are heat-sensitive. A product that says “shelf stable” should back that up with stability testing data showing viable CFU at room temperature through expiration. If it doesn’t, be skeptical.

The Evidence Hierarchy

Not all probiotic claims are equal. Some strains are backed by Cochrane-level systematic reviews; others rest on one small trial in a specific population. When you see marketing language like “clinically studied,” check which tier of evidence the product is riding.

📊Tier 1 — Strong evidence (multiple RCTs + meta-analyses)
LGG (L. rhamnosus GG): 2013 Cochrane review of 23 RCTs for pediatric acute gastroenteritis showed reduced diarrhea duration by roughly 25 hours.
S. boulardii CNCM I-745: 2017 JAMA meta-analysis of 82 RCTs showed ~60% reduction in C. difficile diarrhea when co-administered with antibiotics in high-risk groups.
B. longum 35624 (Alflorex): Multiple RCTs published in Gastroenterology and Alimentary Pharmacology & Therapeutics showed composite IBS symptom improvement at 1 billion CFU. Strong evidence
📊Tier 2 — Moderate evidence (few RCTs, consistent direction)
LP299V (L. plantarum 299v): Several RCTs showing IBS bloating and pain reduction; effect sizes variable across studies.
BB-12 (B. animalis subsp. lactis): Evidence for bowel regularity and some immune markers; results in healthy adults more mixed than in infants.
L. reuteri DSM 17938: Infant colic RCTs in breastfed babies are positive; formula-fed results are inconsistent.Moderate evidence
⚠️Tier 3 — Weak or preliminary evidence
Most multi-strain “broad spectrum” blends. Strains with a single small trial. Any product making claims about mood, weight, skin, or immunity based on mechanistic reasoning without a named strain and RCT backing. The research may come; for now, the dollar value is marketing more than medicine.

A practical rule: if a product’s marketing leans on the word “probiotic” generically rather than naming a specific strain plus the condition it’s been studied for, you’re in Tier 3. The strong-evidence products are almost always boring — one or two named strains, a specific condition, a studied dose.

When Probiotics Won’t Help

Some conditions consistently fail to respond to probiotic supplementation, despite marketing suggesting otherwise. Knowing when to skip the probiotic aisle is as valuable as knowing what to buy.

  • Chronic constipation as a standalone complaint. Fiber, hydration, and magnesium oxide/citrate all outperform probiotics here. Probiotic effects on transit time are small and strain-dependent.
  • SIBO (small intestinal bacterial overgrowth). Conventional Lactobacillus probiotics can worsen SIBO symptoms by adding to the bacterial load in the wrong part of the gut. Spore or S. boulardii may be tolerated; diagnosis first is critical.
  • Weight loss. The “probiotic for weight management” category has extremely thin evidence. Modest signals exist for specific strains (L. gasseri, L. plantarum) but effect sizes are 1–3 lb over 12 weeks — not clinically meaningful.
  • Generalized immune support in healthy adults. Probiotics have stronger immune effects in specific scenarios (antibiotics, daycare-age children, athletes in heavy training) than in the average adult. For baseline immune support in otherwise-healthy adults, vitamin D and zinc have stronger evidence than most probiotic formulations.
  • During active gut inflammation (IBD flare). Evidence is strain-specific and nuanced; self-supplementing during active Crohn’s or UC flares can worsen symptoms. Work with a GI specialist.

Condition-to-Strain Cheat Sheet

If you have a specific goal, start here. This is where the research actually converges — generic “gut health” probiotics are vague by design; strain-condition matching is not.

Match your goal to a studied strain
✓ Synergy
Antibiotic-associated diarrhea
+
S. boulardii CNCM I-745 or LGG
Meta-analyses show roughly 50% reduction in antibiotic-associated diarrhea with either strain. S. boulardii is yeast-based and naturally antibiotic-resistant.
5–10 billion CFU daily of S. boulardii, starting day 1 of antibiotics and continuing 1–2 weeks after.
✓ Synergy
IBS — bloating and pain
+
B. longum 35624 (Alflorex) or LP299V
Multiple RCTs show measurable improvement in composite IBS symptom scores at 4–8 weeks.
1 billion CFU B. longum 35624, or 10–20 billion CFU LP299V. Give it 4 weeks before judging effect.
✓ Synergy
Traveler's diarrhea prevention
+
S. boulardii CNCM I-745
Cochrane reviews show ~15% absolute risk reduction in travelers taking S. boulardii prophylactically.
5 billion CFU daily, starting 5 days before travel and continuing throughout the trip.
✓ Synergy
Recurrent vaginal/UTI issues
+
L. rhamnosus GR-1 + L. reuteri RC-14
Urogenital strains with evidence for reducing BV and UTI recurrence. Different from gut strains.
1–10 billion CFU of each, oral daily for 30+ days. Strain designations matter enormously here.
✓ Synergy
Infant colic
+
L. reuteri DSM 17938
RCTs show reduced crying time in breastfed colicky infants; less consistent in formula-fed.
100 million CFU daily, 5 drops typically. Only under pediatrician supervision.
✓ Synergy
General gut health / maintenance
+
Multi-strain with LGG, BB-12, and a Bifidobacterium
Weakest evidence category — no strong consensus. Fermented food may be equal or better.
If supplementing, choose a simple 2–3 strain product with disclosed individual CFU. Consider kefir, yogurt, sauerkraut instead.

The 4-Week Starter Protocol

Most probiotic users make two mistakes: they switch products every time they don’t feel dramatic results in a week, and they have no plan for evaluating whether it’s working. Here’s a structured 4-week protocol that lets you actually judge a probiotic on its merits.

Week 0: Baseline (Before You Start)

Spend three days tracking before you take your first capsule. You can’t tell if a probiotic helped if you don’t know your starting point. Log daily:

  • Bowel movements — frequency, consistency (Bristol scale 1–7), urgency
  • Bloating — 1–10 scale, worst time of day
  • Energy — 1–10 morning/afternoon/evening
  • Any target symptom — IBS pain, reflux, eczema flare, whatever prompted you to try a probiotic

Week 1: Introduction

Start at half the recommended dose for the first 3–5 days. This reduces the initial bloating / gas most people experience as gut microbial populations shift. Take with food (especially a meal with some fat) unless the product instructions say otherwise. By day 5–7, move to the full dose.

Expect mild GI adjustment symptoms this week — that’s your microbiome changing, not a failure of the product. If symptoms are severe (cramping, diarrhea beyond day 7), either the dose is too high or the strain is wrong for you.

Weeks 2–3: Consolidation

Hold at the full dose. Don’t add new supplements. Don’t switch strains. Don’t change your diet dramatically — you need a stable background to isolate the probiotic’s effect.

Add prebiotic fiber to your diet if you aren’t already. Probiotics colonize better when there’s substrate for them to feed on. Good sources: oats, lentils, beans, onions, garlic, asparagus, green bananas, and fermented foods like sauerkraut and kefir. Target 25–35g total fiber per day.

Continue your daily log. Most probiotic benefits appear in this window, not earlier. If you’re going to see a signal, it usually shows up somewhere between day 10 and day 21.

Week 4: Evaluation

Compare your week-4 averages to your week-0 baseline. This is where most people skip the critical step — they rely on memory instead of data. Memory is biased toward the last few days and toward the symptom you’re most aware of.

Three possible outcomes:

  • Clear improvement in your target symptom or at least two tracked metrics — continue the same product. Re-evaluate at 8 and 12 weeks.
  • No change after 4 weeks at full dose with prebiotic fiber — the product/strain isn’t working for you. Switch to a different strain matched to your target condition (see the cheat sheet above) and repeat the protocol.
  • Worsening symptoms — stop. This is rare but suggests either SIBO, histamine intolerance, or a strain that doesn’t match your gut ecology. Consider a GI workup before trying another product.
💡The single biggest protocol mistake
Quitting at day 7 because nothing happened. Most probiotic benefits take 10–21 days to manifest. If you switch products weekly based on feel, you’ll never actually learn what works.

The Antibiotic Protocol

This is the single highest-evidence use case for probiotics, and it’s often done wrong. The common mistake is taking the probiotic at the same time as the antibiotic — which kills most bacterial strains outright.

  1. Start on day 1 of antibiotics, not after. Waiting until the course is over means you’ve already lost the protective window.
  2. Separate antibiotic and probiotic doses by at least 2 hours.If your antibiotic is twice daily at 8am and 8pm, take the probiotic at 2pm. S. boulardii is the exception — as a yeast, antibiotics don’t affect it, so timing is flexible.
  3. Continue 1–2 weeks after the antibiotic course ends.Gut microbial recovery takes longer than the prescription. Stopping on the last antibiotic day is premature.
  4. Pair with dietary fiber. Probiotics colonize better when there’s prebiotic substrate available. Oats, lentils, onions, garlic, and fermented foods all help.
📊What the evidence supports
A 2017 meta-analysis in JAMA of 82 RCTs found probiotic use during antibiotic therapy reduced the incidence of C. difficile–associated diarrhea by roughly 60% in high-risk populations. The largest effects came from S. boulardii and LGG at clinically validated doses.

The Red Flag Checklist

⚠️If a probiotic does any of these, think twice
No strain designations listed. Advertises 30+ strains as a selling point. Guarantees CFU only at manufacture. Uses proprietary blends with undisclosed per-strain amounts. Claims to support 5+ health outcomes.

If a probiotic product does any of these, think twice:

  • Lists no strain designations — just genus and species. Without the strain code, you can’t verify any clinical evidence. This eliminates the majority of products on shelves.
  • Advertises “30+ strains!” as a selling point — more strains usually means less of each. The best-studied probiotic products use 1–4 strains at individually validated doses.
  • Guarantees CFU only at manufacture — this is effectively meaningless. Demand “through expiration date.”
  • Uses a proprietary blend with undisclosed per-strain amounts — you need to know how much of each strain you’re getting. (See our label reading guide for more on proprietary blends.)
  • Claims to support 5+ health outcomes — “immune, digestive, mood, weight, skin, energy!” No single probiotic product has evidence for all of these. This is marketing, not science.

What to Actually Look For

A quality probiotic should have:

  • Specific strain designations (e.g., L. rhamnosus GG, not just L. rhamnosus)
  • Clinical evidence for those specific strains at the doses provided
  • CFU guaranteed through expiration date
  • Individual CFU counts per strain, not just a total
  • A delivery mechanism that addresses stomach acid survival
  • Clear storage instructions (refrigerated or shelf-stable with supporting data)
  • Third-party testing for purity and potency

Probiotic Safety: Who Should Not Self-Supplement

Probiotic safety is rarely discussed on supplement labels, but for certain populations, live microbial products carry real — not theoretical — risk. Most healthy adults tolerate well-studied strains without issue. The people below are not in that category.

Immunocompromised Patients

If your immune system is significantly suppressed — chemotherapy, organ transplant anti-rejection drugs, advanced HIV/AIDS, or high-dose corticosteroids — live probiotics can cause bacteremia or fungemia (organisms entering the bloodstream). Case series documented by Oggioni et al. (1998) and Enache-Angoulvant & Hennequin (2005) report Lactobacillus bacteremia and Saccharomyces boulardii fungemia in immunocompromised hosts. Moderate evidence These aren't common events in the general population, but the consequences are severe enough that the risk calculation changes entirely.

⚠️S. boulardii and critically ill patients
S. boulardii fungemia has been documented in ICU and severely ill patients, including cases linked to central venous catheters in the same room where the probiotic was being administered (Lherm et al., 2002). If you are hospitalized or critically ill, do not take S. boulardii — or any live probiotic — without explicit approval from your treating physician.

Patients on Immunosuppressants

This includes biologics (infliximab, adalimumab), calcineurin inhibitors (tacrolimus, cyclosporine), and other agents that blunt immune surveillance. Even if you feel fine, your ability to contain a translocating organism is compromised. Consult your prescribing specialist before adding any live microbial supplement to your regimen.

Active IBD Flares

During an active Crohn's or ulcerative colitis flare, gut barrier integrity is already compromised — meaning organisms have an easier path from the intestinal lumen into systemic circulation. Some strains (like E. coli Nissle 1917) have evidence in maintaining UC remission, but that's a different clinical scenario from active inflammation. Moderate evidence Self-supplementing during a flare without GI supervision is not a gray area — it's a clear "don't." Work with your gastroenterologist on strain selection and timing.

If you fall into any of these groups, the issue isn't whether probiotics might help — it's that the downside risk outweighs any plausible benefit without medical oversight.

Vaginal Microbiome and Women's Health Probiotics

Women searching for the best probiotic for vaginal health face a market flooded with vague "feminine balance" claims. The reality is more specific — and more honest. Only a handful of strains have been studied for vaginal microbiome restoration, and the evidence, while promising, is thinner than what exists for the GI strains covered above.

The Strains That Actually Have Data

L. crispatus CTV-05 (LACTIN-V) is the standout. A 2020 RCT by Cohen et al. published in the New England Journal of Medicine found that vaginally applied L. crispatus after standard metronidazole treatment reduced BV recurrence to 30% versus 45% in the placebo group at 12 weeks. Moderate evidence That's meaningful, but it was a single trial (n=228) and the product is administered vaginally — not orally.

The L. rhamnosus GR-1 + L. reuteri RC-14 combination (marketed as Fem-Dophilus) has a longer publication history. Oral supplementation was studied across several small RCTs by Reid et al. (2003, 2006), showing improvements in vaginal flora composition and modest reductions in BV recurrence. Effect sizes varied, and sample sizes were generally under 100. Emerging evidence

An Honest Look at Evidence Quality

There is no Cochrane-level systematic review specifically for probiotics and BV prevention as of this writing. Most trials are small, short-duration, and conducted by researchers affiliated with the product developers. A 2019 Cochrane review on probiotics for treating BV (Mastromarino et al.) found low-certainty evidence that probiotics may increase cure rates when used alongside antibiotics, but called for larger, better-designed trials.

⚠️Route of administration matters
Most positive vaginal microbiome data comes from vaginally applied probiotics, not oral capsules. The assumption that swallowing a Lactobacillus capsule reliably colonizes the vaginal tract is plausible but not firmly established. If BV recurrence is your concern, discuss both oral and vaginal options with your healthcare provider.

If you're considering a probiotic specifically for vaginal health, look for products naming L. crispatus, L. rhamnosus GR-1, or L. reuteri RC-14 on the label — with strain designations, not just species. Anything labeled generically as a "women's probiotic" without these specifics is riding marketing, not evidence. And as with every probiotic decision, strain identity is what separates a studied product from a guess.

How to Read a Probiotic Label in 60 Seconds

Knowing how to read a probiotic label is the single most practical skill this guide can give you. Everything discussed above — strain designations, CFU guarantees, delivery mechanisms — lives or dies on what's actually printed on the back of the bottle. Here's what to scan for, in order, the next time you're standing in a pharmacy aisle.

The Good Label: What You Want to See

Start at the Supplement Facts panel. A quality product lists each organism by genus, species, and strain designation — e.g., Lactobacillus rhamnosus GG, not just L. rhamnosus. That alphanumeric code after the species name is your only link to clinical evidence. No code, no way to verify anything.

Next, check whether CFU counts are broken out per strain, not just a blend total. You need to know each strain hits its studied dose individually. A line reading "L. rhamnosus GG — 10 billion CFU" tells you something useful. "Proprietary Probiotic Blend — 50 billion CFU" tells you almost nothing.

Now find the CFU guarantee language, usually in small print below the panel. It should say "at expiration" or "through best-by date." If it says "at time of manufacture" — or says nothing at all — assume significant die-off by the time you open the bottle.

Finally, look for a third-party testing seal (USP, NSF International, or ConsumerLab) typically placed on the front label or near the barcode. This confirms an independent lab verified potency and purity. Fewer than 10% of probiotic products carry one.

The Red-Flag Label: What to Walk Away From

A red-flag label lists 15–30 strains by genus and species only — no strain codes anywhere. CFU is presented as a single blend total ("60 billion CFU†") with a footnote reading "at time of manufacture." Per-strain amounts are hidden behind a "proprietary blend" disclosure, making dose verification impossible. No third-party seal appears anywhere on the packaging. The front panel promises support for digestion, immunity, mood, weight, and skin. That's marketing breadth substituting for clinical depth.

ℹ️60-Second Scan Order
1. Strain designations present? → 2. Per-strain CFU listed? → 3. CFU guaranteed at expiration? → 4. Third-party seal? If a product fails any of the first three checks, put it back. For a deeper breakdown of proprietary blend tactics, see our label reading guide.

Recommended Products by Condition (With Strain Verification)

Knowing which strains to look for is only useful if you can find recommended probiotic products by condition that actually contain those strains at studied doses. We verified each product below by cross-referencing its current label against the licensed strain and the dose used in clinical trials. If a product changed its formulation or dropped its strain designation, it didn't make this list.

Antibiotic-Associated Diarrhea Prevention

Culturelle Digestive Daily — contains L. rhamnosus GG at 10 billion CFU, with a CFU-through-expiration guarantee. This matches the dose and strain from the 2013 Cochrane review (Allen et al., 2010) and subsequent AAD trials. Strong evidence Florastor — contains S. boulardii CNCM I-745 at 5 billion CFU per capsule (10 billion at the two-capsule daily dose). As a yeast, it survives concurrent antibiotic use — no timing gymnastics required. Matches the strain from the 2017 Goldenberg et al. JAMA meta-analysis.

IBS (Bloating and Abdominal Pain)

Jarrow Formulas Ideal Bowel Support 299v — delivers L. plantarum 299v at 10 billion CFU. Multiple RCTs (Ducrotté et al., 2012; Niedzielin et al., 2001) used this strain at this dose for IBS bloating and pain. Alflorex (Precision Biotics) — the only product using B. longum 35624 at the exact 1 billion CFU dose from the Whorwell et al. (2006) Gastroenterology trial. Single-strain, low-dose, condition-specific — the opposite of a kitchen-sink blend.

Infant Colic (Breastfed Infants)

BioGaia Protectis Baby Drops — delivers L. reuteri DSM 17938 at 100 million CFU per five drops. This matches the Savino et al. (2007) and Szajewska et al. (2013) trial protocols.

⚠️Always Verify the Current Label
Manufacturers reformulate without announcement. Before purchasing any product on this list, confirm the strain designation and CFU-through-expiration guarantee on the actual label or the brand's current website. A product that contained the right strain last year may not today.

General Regularity and Immune Support

Chr. Hansen's BB-12 products (e.g., Culturelle Baby Calm + Comfort, or region-specific licensed brands)B. animalis subsp. lactis BB-12 at 1–10 billion CFU. Evidence is stronger in infants and elderly populations than in healthy adults (Eskesen et al., 2015). Moderate evidence If your target condition isn't listed here, revisit the strain-condition cheat sheet above and look for a product that names the exact strain designation on its label. No strain code, no buy.

Probiotics During Pregnancy and for Infants

Probiotics during pregnancy occupy an unusual space: high anxiety, heavy marketing, and a safety profile that's actually more reassuring than most people expect — for the right strains. The key word is "right." Strain identity matters even more here than it does for general adult use, because the evidence base is narrower and the stakes feel higher.

Safety in Pregnancy: LGG and BB-12

Both L. rhamnosus GG (LGG) and B. animalis subsp. lactis BB-12 carry EFSA Qualified Presumption of Safety status and FDA Generally Recognized as Safe (GRAS) designations. Multiple RCTs — including Luoto et al. (2010) and Rautava et al. (2012) — have administered these strains throughout pregnancy and into the postnatal period without increased adverse events for mother or infant. Moderate evidence A 2018 systematic review by Jarde et al. in CMAJ covering over 6,000 pregnant participants found no association between probiotic use and miscarriage, malformation, or preterm birth.

ℹ️Strain specificity matters here, too
These safety data apply to LGG and BB-12 specifically, at studied doses (typically 1–10 billion CFU). They do not extend to every product labeled "probiotic." Consult your OB or midwife before starting any supplement during pregnancy — especially high-CFU multi-strain blends without strain designations.

L. reuteri DSM 17938 for Infant Colic

This is the most-studied probiotic strain for infant colic, and the evidence splits cleanly along feeding type. In exclusively breastfed infants, multiple RCTs — notably Savino et al. (2010) and Szajewska et al.'s 2014 meta-analysis — show L. reuteri DSM 17938 at 10⁸ CFU/day reduced crying time by roughly 50 minutes per day versus placebo. In formula-fed infants, results are inconsistent. Sung et al. (2014) — a large, well-designed Australian trial that included both breastfed and formula-fed babies — found no significant benefit in the formula-fed subgroup. The honest summary: if you're breastfeeding, the signal is real. If you're formula-feeding, don't expect the same results.

GBS Prevention: The Evidence Isn't There Yet

Group B Streptococcus (GBS) colonization affects roughly 25% of pregnant women, and the idea of a probiotic alternative to intrapartum antibiotics is understandably appealing. But the current evidence is weak. Emerging evidence A handful of small, mostly observational studies have explored oral or vaginal Lactobacillus strains for reducing GBS colonization. None have demonstrated reliable decolonization in adequately powered RCTs. Do not substitute probiotics for standard GBS screening and antibiotic prophylaxis based on current data.

⚠️GBS is not a DIY situation
Intrapartum antibiotic prophylaxis remains the standard of care for GBS-positive mothers. If you encounter products marketed for GBS prevention, recognize that no strain has sufficient clinical evidence to replace established protocols. Discuss any interest in adjunctive probiotics with your obstetric provider.

Who Should Talk to a Doctor First

The strains discussed in this guide are generally well-studied in healthy adults, but probiotics are live organisms — and that matters more for some people than others. If any of the following apply to you, get clinical input before starting.

⚠️If you are immunocompromised
Live microbial supplements pose a documented infection risk in immunocompromised individuals — including cancer patients on chemotherapy, organ transplant recipients, and those with advanced HIV. Case reports of S. boulardii fungemia exist in critically ill patients. Talk to your specialist before taking any live probiotic.
⚠️If you are pregnant or breastfeeding
Some strains discussed here (LGG, BB-12) have reassuring pregnancy data, but safety profiles vary by strain and dose. Talk to your OB or midwife before starting a probiotic — especially high-CFU formulations.
⚠️If you are 65 or older
Age-related shifts in gut microbiome composition — particularly declining Bifidobacterium — and higher antibiotic exposure may change which strains and doses are appropriate. Discuss strain selection with your healthcare provider, especially if you have a history of C. difficile infection.
⚠️If you suspect SIBO
The relationship between conventional Lactobacillus probiotics and SIBO is contested in the literature, not settled. Do not self-diagnose or self-treat based on this guide. Get a proper workup from a GI provider before adding or avoiding any probiotic.
⚠️If you have histamine intolerance
Certain Lactobacillus strains can influence histamine levels in the gut. If you have known or suspected histamine intolerance, consult your healthcare provider about strain-specific considerations before starting.

None of the above is medical advice. Bring your full supplement list — including what you're considering — to your next provider visit.

Frequently Asked Questions

Should I take a probiotic every day?

Most probiotic strains don’t colonize your gut permanently — they pass through over 1–3 weeks. For ongoing benefits, daily supplementation is typically needed. If you’re taking a probiotic for a specific event (like during antibiotics), you can stop afterward — most practitioners recommend continuing for 1–2 weeks after the antibiotic course ends.

Can probiotics cause side effects?

Mild bloating and gas are common when starting a probiotic — they usually resolve within a few days to a week as your microbiome adjusts. If symptoms persist or worsen, try reducing the dose or switching strains. People with SIBO (small intestinal bacterial overgrowth) should consult a doctor before starting probiotics, as they can sometimes worsen symptoms.

Are probiotic foods (yogurt, kefir, kimchi) better than supplements?

They’re different. Fermented foods provide a diverse range of organisms and have strong epidemiological evidence for gut health. But you can’t control which strains or how many CFU you’re getting. Supplements give you specific strains at known doses. Ideally, eat fermented foods regularly AND supplement a specific strain if you have a targeted goal.

Do I need to refrigerate my probiotic?

Depends on the product. Traditional Lactobacillus and Bifidobacterium products often need refrigeration. Spore-based (Bacillus) and yeast-based (S. boulardii) probiotics are inherently shelf-stable. If a conventional probiotic claims to be shelf-stable, check whether the CFU guarantee accounts for room temperature storage through expiration. When in doubt, refrigerate.

Are probiotic CFU counts meaningful?

Partially. CFU (colony-forming units) tells you how many live bacteria are in the capsule, but not how many reach your gut alive. A 50 billion CFU product without enteric coating may deliver fewer live bacteria than a 10 billion CFU product that survives stomach acid. Strain survivability and delivery method matter more than raw CFU.

What probiotic strains have the best evidence?

Lactobacillus rhamnosus GG and Saccharomyces boulardii have the strongest RCT evidence, primarily for antibiotic-associated diarrhea and IBS symptoms. Bifidobacterium longum 35624 has evidence for IBS. Outside these well-studied strains, most probiotics have only weak or inconsistent trial support.

Do probiotics need to be refrigerated?

Depends on the strain and formulation. Many modern probiotics use lyophilized (freeze-dried) strains in blister packs and are shelf-stable. Refrigeration matters most for cheap bulk-bottle products exposed to humidity and heat. Check the label — a quality product will say 'no refrigeration required' or give a shelf-life guarantee.

What probiotic brands actually contain LGG or LP299V?

The guide doesn't name specific brands — it focuses on how to evaluate any product by strain designation, dose, and CFU guarantee. To find products containing a specific strain, search the strain name (e.g., "L. rhamnosus GG" or "L. plantarum 299v") directly on a retailer or the manufacturer's site, then verify the product meets the guide's criteria: strain code listed, CFU guaranteed through expiration, and individual per-strain counts disclosed.

Can I take probiotics while pregnant?

The guide doesn't cover probiotic use during pregnancy. This is a meaningful gap — pregnancy involves specific considerations around strain safety, immune modulation, and conditions like Group B Strep or gestational constipation that require clinical guidance. Consult your OB-GYN or midwife before starting any probiotic during pregnancy. Do not rely on general supplement guidance for this decision.

What probiotic should I take for vaginal health or BV?

The guide doesn't address vaginal health or bacterial vaginosis — its condition coverage is entirely GI-focused. Vaginal microbiome support (including BV) involves specific strains such as L. crispatus and the L. reuteri RC-14 + L. rhamnosus GR-1 combination that the guide does not evaluate. For evidence-based guidance on this use case, consult a gynecologist or a clinician familiar with the vaginal microbiome literature.

How long should I stay on a probiotic before stopping?

It depends on your goal. The guide's 4-week protocol gives a structured evaluation window: if you see clear improvement, continue and reassess at 8 and 12 weeks. For event-based use — like antibiotic support — the guide recommends stopping 1–2 weeks after the course ends. For ongoing conditions like IBS, daily supplementation is typically needed since most strains don't permanently colonize. If symptoms resolve, reassess whether continued use is still warranted.

Are probiotics safe for kids and what dose?

The guide doesn't provide pediatric dosing guidance or age-specific product recommendations. It does reference positive Cochrane-level evidence for LGG in pediatric gastroenteritis and notes L. reuteri DSM 17938 has positive RCT data for infant colic in breastfed babies. For weight-based dosing, appropriate age ranges, or product form (chewable vs. capsule), consult a pediatrician — do not extrapolate adult doses to children.

What is the difference between spore-based probiotics (Bacillus) and regular probiotics?

Spore-based probiotics use Bacillus strains that form protective endospores, surviving stomach acid, heat, and room-temperature storage without refrigeration. The guide notes this as a delivery advantage over conventional Lactobacillus and Bifidobacterium strains. The tradeoff: the guide explicitly states spore-based products have a "different and smaller evidence base" than well-studied strains like LGG or LP299V, without evaluating specific Bacillus strains or products. Apply the same standard — demand named strain designations and published RCT evidence, not just survival claims.

Does taking a probiotic interact with my medication?

The guide covers one drug interaction: separate bacterial probiotic doses from antibiotics by at least 2 hours (S. boulardii is the exception, as a yeast it's unaffected). Beyond this, the guide is silent on interactions with immunosuppressants, proton pump inhibitors, chemotherapy, or other medications. These are safety-critical gaps. If you are immunocompromised or on any prescription medication, consult a pharmacist or physician before starting a probiotic.

Supporting the Gut Beyond the Capsule

A probiotic is one lever, not the whole system. The gut-barrier and microbiome work the research consistently points to also includes long-chain omega-3 fatty acids (anti-inflammatory effect on the gut lining), magnesium for motility when constipation is part of the picture, and in some cases collagen-derived glycine and proline for epithelial repair. Put another way: the probiotic is the seed; the rest of your stack is the soil.

The Bottom Line

Stop shopping for probiotics by CFU count or number of strains. Start shopping by evidence. Identify what you want the probiotic to do, find a product using clinically studied strains for that specific purpose at validated doses, and verify it has a delivery mechanism that gets the organisms past your stomach acid alive. It’s a smaller pool of products than the aisle suggests — but the ones that pass are the ones that actually work.

Browse probiotic supplements in the Formulate catalog →

See full scores in Formulate

Every product scored 50–100 against clinical research. Compare brands, check dose safety, and build your stack — free, no account required.

Interactions to know

How these pair with other supplements and medications

Open the checker →

Check your full stack in the free interaction checker.

📬 Get new guides in your inbox

Evidence-based supplement guides, no spam

We send a short digest when new guides drop — nothing else. No affiliate pushes, no sponsored content, unsubscribe anytime.